The value of these mergers will really be dependent on how rapidly and effectively they can change the retail pharmacy setting, said Dan Mendelson, MPP, founder, Avalere Health.
The value of these mergers will really be dependent on how rapidly and effectively they can change the retail pharmacy setting, said Dan Mendelson, MPP, founder, Avalere Health.
TranscriptWhat concerns or expectations do you have for cross-sector mergers like the one between CVS and Aetna?
I think that the value of these mergers will really be dependent on how rapidly and effectively they can change the retail pharmacy setting. The retail pharmacy setting right now, as I said, is not one that is conducive to profitability. It also has so much potential, because the reality is patients trust their pharmacists more than they trust their doctors, more than they trust pretty much anybody else, certainly more than they trust the pharmaceutical company. So, when you look at trust, pharmacists, they rank up there.
So, it’s a setting in which you have a really trusted healthcare professional and pharmacists are really not being fully deployed. The other thing that I think holds a lot of potential is the ability to deliver data at the pharmacy level. The pharmacist should know more about the patient. The pharmacist should know, for example, whether the patient needs a mammogram or not, or whether the patient has gone in to have his cholesterol checked or whether the patient has had a colonoscopy, if the patient needs one.
Right now, the pharmacist doesn’t know that, so getting data, information, and really the ability to engage with patients to the pharmacy counter can really improve the value of what is being delivered in that setting. So, I think that as I look at the combinations, at the business combinations, their ability to really change and leverage in those kinds of value propositions will determine how effective they are.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More